Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Gets ISO Accreditation for Microarray-Based Breast Cancer Diagnostic

NEW YORK, Sept. 5 (GenomeWeb News) - Agendia, a Dutch firm that specializes in gene-expression services, said today that it has been granted ISO 17025 accreditation for its MammaPrint service, which assesses the risk of metastasis in breast cancer patients.

 

According to the company, it is the first to be granted this accreditation for a microarray-based diagnostic test.

 

Agendia said that the accreditation is granted for four years, but that the Dutch Accreditation Council will perform yearly inspections of the Agendia laboratory facilities in order to confirm that the company meets the ISO requirements.

 

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.